The pharmaceutical market of the Republic of Belarus is represented by fifty players - manufacturers of medicines, the greatest influence of which belongs to the Republican Unitary Production Enterprise "Belmedpreparaty" as it is the largest manufacturer of national pharmaceutical products.

Production facilities include 14 technological and 6 auxiliary workshops.

The workshops are located on four sites: two - in the city of Minsk (30, Fabricius Street and 1, Mayakovsky Street), one - in the city of Lida and one - in the city of Skidel. 

The organization of production of medicines at RUE "Belmedpreparaty" corresponds to the tasks set by the Government of the Republic of Belarus to the pharmaceutical industry in particular:

- complete satisfaction of medical institutions needs and the population of the Republic of Belarus in medicinal products;

-  creation at RUE "Belmedpreparaty" of medicinal products modern productions corresponding to international GMP standards; 

-  preservation and strengthening of organization's market positions, both on the national and foreign markets;

-  updating of basic industrial production assets of the enterprise.

The investment program of the company in 2017-2018 is aimed at implementation of investment and innovation projects for modernization, technical re-equipment of existing production and creation of new production facilities.

In 2017 -2018 the enterprise carries out the following projects:

-    Creation of pilot production of oral antitumor medicinal products in the performance of isolation technologies type at RUE "Belmedpreparaty";

-    Technical re-equipment of the existing production of RUE "Belmedpreparaty".

Project "Creation of pilot production of oral antitumor medicinal products in the performance of isolation technologies type at RUE "Belmedpreparaty".

The aim of the project is to create a pilot production of oral antitumor medicinal products in the performance of isolation technologies type at RUE "Belmedpreparaty".

For implementation, it is planned to carry out construction and installation works, purchase and install new high-tech equipment for the production of medicines in the form of tablets and capsules in the performance of isolation technologies type.

Installation of acquired equipment is planned on the existing areas of the enterprise using the existing engineering infrastructure.

The project will be implemented between 2017 and 2020.

Capital expenditures including VAT (according to the updated calculation of 2017) for this project will amount to about 14804 thousand USD.

Sources of project financing planned in 2017:

- Own funds of the enterprise;

- Funds of Innovation fund of the Minsk City Executive Committee on an irretrievable basis.

Event "Technical re-equipment of the existing production of RUE "Belmedpreparaty".

The project is aimed at increasing the technical level of current production of medicines at RUE "Belmedpreparaty" and bringing it into compliance with the requirements of international standards GMP by introducing more modern technics and technology, mechanization and automation of production, modernization and replacement of obsolete and physically worn out equipment.

Investments in 2017 for the event "Technical re-equipment of current production of RUE "Belmedpreparaty" will be about 21500 thousand BYN.

Planned sources of financing for the event:

-  Own funds of the enterprise.

RUE "Belmedpreparaty" has a rich experience in the implementation of investment and innovation projects.

In 2012-2016, the enterprise implemented a number of investment projects, the ultimate goal of which was the creation of productions meeting GMP standards.

The most significant of them are:

-  "Reconstruction of production of antitumor agents in the form of freeze dried powders and solutions for injection";

- "Creation of new production capacities for medicinal products produced by RUE "Belmedpreparaty", corresponding to the international GMP standards.

RUE "Belmedpreparaty" is the first in the Republic of Belarus, producing medicinal products for the treatment of oncological diseases.

Within the project "Reconstruction of the production of antitumor agents in the form of freeze dried powders and solutions for injections", included in the "State Program of Innovative Development of the Republic of Belarus for 2011-2015", the company organized the production of antitumor medicinal products.

Capital expenditures including VAT on the project amounted to about 35500 thousand USD.

This investment project is extremely complex and unique for the Republic of Belarus and the CIS countries.

The project was implemented in two stages:

The 1st launch complex is the creation of production of antitumor medicinal products  in the form of lyophilized powders and solutions for injection (ampoules and vials) that are not cytostatics (commissioned in June 2013).

The 2nd launch complex is the creation of production of cytostatic antitumor medicinal products  in the performance of isolation technologies type (commissioned in December 2013).

The use of isolating technologies allows to ensure the implementation of technological processes on equipment completely isolated from personnel and the production environment, and ensures the absence of emissions into the atmosphere, which is fundamentally new for the Republic of Belarus, as well as for the CIS countries.

When implementing the project, modern equipment was purchased that meets the requirements of safety and industrial hygiene standards, GMP requirements, which allows to carry out highly efficient technological processes. The built-in monitoring and control system with technological parameters allows monitoring processes in the on-line mode, which significantly improves the quality of the products.

The organization and development of the production of antitumor medicinal products  allowed the company:

-  To expand the nomenclature of medicinal products;

-  To create the production of antitumor medicinal products, corresponding not only to national, but also to international standards of Good Manufacturing Practices (GMP);

-  To increase the export potential and expand the opportunities for the realization of this product, both on the national and foreign markets;

-   Ensure guaranteed high quality and safety of manufactured medicinal products;

-  Increase production capacity;

-  To improve the overall economic indicators of development, both by increasing revenue from sales of products, and by reducing production costs, resulting in increased productivity;

-  Satisfy the needs of medical institutions and the population of the Republic of Belarus in medicines in full.

On the production site in the city of Lida in 2013-2015, the implementation of the investment project "Creation of new production capacity for medicinal products produced by RUE "Belmedpreparaty", corresponding to the international GMP standards", was carried out.

As a result of the project, production of sterile prepackaged antibiotics in vials of 10ml and 100 ml was launched.

Capital expenditures including VAT on the project amounted to about 27700 thousand USD.

The implementation of the investment project allowed to RUE "Belmedpreparaty":

-  To expand the export potential and the possibility of selling products both on the national and foreign markets by bringing production in line with the requirements of international GMP standards;

-  More fully meet the needs of medical institutions and the population of the Republic of Belarus and CIS countries in medicinal products;

-  Ensure guaranteed high quality and safety of manufactured medicinal products;

-  Improve working conditions for personnel as a result of the introduction of modern production technologies.

Application of modern progressive technical and technological solutions meeting the international quality GMP standards allowed to produce medicinal products that fully correspond to foreign analogues, are competitive with them, both in terms of quality characteristics and price factor. This preserves and strengthens the market positions of the enterprise.

Consequently, RUE "Belmedpreparaty" has extensive experience in successful implementation of investment projects.